Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 207-136-1 | CAS number: 443-48-1
Carcinogenicity
Administrative data
Description of key information
Key value for chemical safety assessment
Justification for classification or non-classification
Metronidazole has been shown to be carcinogenic (lung tumorigenesis and lymphoma) in mice and rats. An increased incidence of tumors in very young patients treated with metronidazole in the long term has raised the suspicion that the metronidazole is potentially carcinogenic in humans. According to the IARC SAFETY DATA SHEET METRONIDAZOLE Edition : 01 Revision: 02 Data: 08/22/2016 page 10 of 13
metronidazole is considered as a possible carcinogen to humans (Group 2B).
On the basis of existing data, it is appropriate to consider the MTZ as a potential human carcinogen, in the presence of sufficient experimental data and human data of limited value. The MTZ is mutagenic in bacterial systems, genotoxic in human cell lines and carcinogenic in animal studies.
Additional information
Data source: European Directorate for the Quality of Medicines & HealthCare (EDQM) - Catalogue code: M1850000, USP Reference Standards - Catalog Number: 1442009, IARC, 1987. Overall Evaluations of Carcinogenicity. IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Humans, Supplement 7. Lyon, France: International Agency for Research on Cancer. 440 pp.; DailyMed Report on Carcinogens, Eleventh Edition, Muller J J A, Bos P M J, 2004. The occurrence of Carcinogenic, Mutagenic and Reprotoxic (CMR) substances in consumer preparations. RIVM report 320010001, pag. 63; EMEA, 1997. Committee for veterinary medicinal products Metronidazole. Summary Report; Data bank www.chemspider.com
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
